Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-22-020892

Options or other derivatives

  • President and CEO acquired 510,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Meeker David P · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-02-09 Grant or award : show line 1 in the form Stock Option (Right to Buy) +510,000 $6.80 2032-02-08 510,000 510,000 D
Loading xslF345X03/tm226394-4_4seq1.xml…